Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0314719 (
dry eye
)
2,625
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dry eye
is a common disease that develops as a result of alteration of tear fluid, leading to osmotic stress and a perturbed epithelial barrier. Matrix metalloproteinase-9 (MMP-9) may be important in
dry eye
disease, as its genetic knockout conferred resistance to the epithelial disruption. We show that extracellular matrix metalloproteinase inducer (
EMMPRIN
; also termed
CD147
), an inducer of MMP expression, participates in the pathogenesis of
dry eye
through MMP-mediated cleavage of occludin, an important component of tight junctions.
EMMPRIN
expression was increased on the ocular surface of
dry eye
patients and correlated with those of MMP-9. High osmolarity in cell culture, mimicking
dry eye
conditions, increased both
EMMPRIN
and MMP-9 and resulted in the disruption of epithelial junctions through the cleavage of occludin. Exogenously added recombinant
EMMPRIN
had similar effects that were abrogated in the presence of the MMP inhibitor marimastat. Membrane occludin immunostaining was markedly increased in the apical corneal epithelium of both
EMMPRIN
and MMP-9 knock-out mice. Furthermore, an inverse correlation between
EMMPRIN
and occludin membrane staining was consistently observed both in vitro and in vivo as a function of corneal epithelial cells differentiation. These data suggest a possible role of
EMMPRIN
in regulating the amount of occludin at the cell surface in homeostasis beyond pathological situations such as
dry eye
disease, and
EMMPRIN
may be essential for the formation and maintenance of organized epithelial structure.
...
PMID:EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. 2177 61